Moolec Science (MLEC) Receivables - Other (2022 - 2026)
Moolec Science's (MLEC) quarterly Receivables - Other came in at $5.2 million in Q1 2026, up 23.81% quarter-over-quarter from $4.2 million in Q4 2025.
Moolec Science (MLEC) Receivables - Other (2022 - 2026) Analysis & Trends
Moolec Science has disclosed Receivables - Other across 5 years of filings, most recently posting $5.2 million for Q1 2026.
- Receivables - Other for Q1 2026 came in at $5.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (changed N/A YoY), and the FY2025 annual result was $13.8 million, up 3667.86% from the prior year.
- Receivables - Other came in at $5.2 million for Q1 2026 at Moolec Science, up from $4.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $34.7 million in Q2 2024 to a low of -$937140.0 in Q1 2023.
- The 5-year median for Receivables - Other is $9065.0 (2023), against an average of $3.9 million.
- Peak annual rise in Receivables - Other reached 23517.88% in 2023, while the deepest fall reached 13505.73% in 2023.
- Moolec Science's Receivables - Other stood at $3876.0 in 2022, then surged by 23517.88% to $915429.0 in 2023, then slumped by 167.81% to -$620719.0 in 2024, then surged by 776.63% to $4.2 million in 2025, then increased by 23.81% to $5.2 million in 2026.
- The last three Receivables - Other figures came in at $5.2 million (Q1 2026), $4.2 million (Q4 2025), and $13.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20 Mn |
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Jun 30, 2025 | 13.85 Mn |
| Jun 30, 2025 | 13.85 Mn |
| Dec 31, 2024 | -620,719.00 |
| Dec 31, 2024 | -620,719.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 34.66 Mn |
| Jun 30, 2024 | 34.66 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 915,429.00 |
| Dec 31, 2023 | 915,429.00 |
| Sep 30, 2023 | 9,065.00 |
| Sep 30, 2023 | 9,065.00 |
| Jun 30, 2023 | -276,292.00 |
| Jun 30, 2023 | -276,292.00 |